In agreement with experimental studies, GLP-1 analogues, particularly liraglutide, sustain the maintenance of β-cell function in obese individuals with early T2D, and these effects are presumably independent of weight loss (42, 43). Here, GCG is linked to type 2 diabetes mellitus.